Knowledge (XXG)

Nifurtimox

Source 📝

511: 488: 958: 989: 40: 1582: 31: 2386: 811:
Use of nifurtimox should be avoided in pregnant women due to limited use. There is limited data shown that nifurtimox doses up to 15 mg/kg daily can cause adverse effects in breastfed infants. Other authors do not consider breastfeeding a contraindication during nifurtimox use.
1509:
Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U, et al. (July 2009). "Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial".
802:
and nifurtimox is safer and easier than treatment with eflornithine alone, and appears to be equally or more effective. It has been recommended as first-line treatment for second-stage African trypanosomiasis.
915:
Nifurtimox forms a nitro-anion radical metabolite that reacts with nucleic acids of the parasite causing significant breakdown of DNA. Its mechanism is similar to that proposed for the antibacterial action of
737:. It is not available commercially in Canada. It was approved for medical use in the United States in August 2020. In regions of the world where the disease is common nifurtimox is provided for free by the 1391:
Pepin J, Milord F, Mpia B, Meurice F, Ethier L, DeGroof D, Bruneel H (1989). "An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire".
772:
in children and adolescents (birth to less than 18 years of age and weighing at least 2.5 kilograms (5.5 lb) for the treatment of Chagas disease (American Trypanosomiasis), caused by
2441: 138: 663: 1908: 1001:
Nifurtimox is licensed for use in Argentina, the United States, Turkey and Germany amongst others. It was approved for medical use in the United States in August 2020.
1429:"Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness" 583: 700: 70: 619: 907:
Nifurtimox is contraindicated in people with severe liver or kidney disease, as well as people with a background of neurological or psychiatric disorders.
1639: 714:
Common side effects include abdominal pain, headache, nausea, and weight loss. There are concerns from animal studies that it may increase the risk of
820:
Side effects occur following chronic administration, particularly in elderly people. Major toxicities include immediate hypersensitivity such as
1645: 2340: 1901: 734: 1718:
Castro JA, de Mecca MM, Bartel LC (August 2006). "Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)".
2133: 1114: 2416: 1576: 639: 1894: 1831: 1784:"Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina" 1607: 1240: 1044: 275: 178: 94: 2406: 2376: 1564: 1120: 1087: 753:, when it is given for 30 to 60 days. However, long-term use of nifurtimox does increase chances of adverse events like 380: 1326: 2357: 467: 113: 787:
involvement). When nifurtimox is given on its own, about half of all patients will relapse, but the combination of
1148: 738: 2436: 2411: 2345: 1955: 1427:
Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, Miaka Mia Bilenge C, Būscher P (February 2007).
780: 692: 233: 124: 506: 2301: 2083: 784: 754: 456: 2446: 2240: 2091: 2087: 769: 594: 1886: 2426: 2001: 1727: 941: 241: 1669:
Forsyth CJ, Hernandez S, Olmedo W, Abuhamidah A, Traina MI, Sanchez DR, et al. (October 2016).
1633: 1191:
Bern C, Montgomery SP, Herwaldt BL, Rassi A, Marin-Neto JA, Dantas RO, et al. (November 2007).
2421: 2141: 2122: 2072: 708: 483: 295: 131: 1985: 1946: 1858: 1761: 1545: 2203: 765:
is now being more considered for those who have Chagas disease and require long-term treatment.
647:
InChI=1S/C10H13N3O5S/c1-8-7-19(16,17)5-4-12(8)11-6-9-2-3-10(18-9)13(14)15/h2-3,6,8H,4-5,7H2,1H3
2431: 2108: 1857:
for "Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma" at
1805: 1753: 1700: 1572: 1537: 1491: 1450: 1409: 1373: 1285: 1214: 193: 52: 436: 1795: 1743: 1735: 1690: 1682: 1527: 1519: 1481: 1440: 1401: 1363: 1275: 1204: 1156: 523: 206: 389: 369: 304: 2390: 2271: 2225: 1875: 1019: 988: 599: 224: 214: 161: 718:
but these concerns have not been found in human trials. Nifurtimox is not recommended in
1731: 971:
Please help update this article to reflect recent events or newly available information.
510: 487: 2351: 2279: 2248: 2177: 2145: 2076: 2035: 2027: 2012: 1977: 1823: 1695: 1670: 1232: 750: 723: 688: 1599: 1523: 1193:"Evaluation and treatment of chagas disease in the United States: a systematic review" 2400: 2283: 2256: 2191: 2181: 2064: 1937: 1917: 1405: 1015: 917: 606: 499: 1800: 1783: 1549: 1280: 1263: 329: 2307: 2297: 2217: 2207: 2039: 2016: 1967: 1928: 1765: 1671:"Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States" 944:. Accumulation of hydrogen peroxide to cytotoxic levels results in parasite death. 799: 762: 704: 696: 156: 151: 146: 1853: 1350:
Jackson Y, Alirol E, Getaz L, Wolff H, Combescure C, Chappuis F (November 2010).
2321: 2311: 2288: 2252: 2195: 2112: 2102: 2098: 1995: 1991: 1981: 933: 832:. Central nervous system disturbances and peripheral neuropathy may also occur. 821: 792: 788: 1739: 2260: 2229: 2213: 2185: 2169: 2045: 937: 921: 829: 727: 559: 360: 1209: 1192: 1079: 2160: 1973: 1963: 1352:"Tolerance and safety of nifurtimox in patients with chronic chagas disease" 1318: 758: 719: 254: 80: 74: 1809: 1757: 1704: 1569:
Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment
1541: 1495: 1454: 1377: 1289: 1218: 1153:
World Health Organization model list of essential medicines: 21st list 2019
39: 22: 1413: 1014:
Nifurtimox is in a phase-II clinical trial for the treatment of pediatric
761:
side effects. Due to the low tolerance and completion rate of nifurtimox,
2317: 2118: 1924: 1921: 1686: 929: 825: 340: 108: 1161: 791:
with nifurtimox appears to be efficacious. Trials are awaited comparing
349: 286:-(3-Methyl-1,1-dioxido-4-thiomorpholinyl)-1-(5-nitro-2-furyl)methanimine 2005: 1748: 1532: 783:(sleeping sickness), and is active in the second stage of the disease ( 315: 30: 1634:"Parasites - American Trypanosomiasis (also known as Chagas Disease)" 920:. Nifurtimox undergoes reduction and creates oxygen radicals such as 795:/nifurtimox against melarsoprol alone for African sleeping sickness. 715: 447: 259: 1565:"Anti-infective agents: Nitrofurans and drugs for urinary infection" 86: 1486: 1469: 1445: 1428: 1368: 1351: 416: 409: 1394:
Transactions of the Royal Society of Tropical Medicine and Hygiene
987: 582: 573: 427: 229: 400: 1890: 187: 103: 951: 472: 1470:"Combination therapy for sleeping sickness: a wake-up call" 1594: 1592: 733:
Nifurtimox came into medication use in 1965. It is on the
1165:. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO. 735:
World Health Organization's List of Essential Medicines
670: 2374: 1233:"Trypanosomiasis, human African (sleeping sickness)" 2270: 2239: 2168: 2159: 2132: 2063: 2026: 1954: 1945: 1936: 605: 593: 571: 558: 522: 517: 498: 466: 446: 426: 399: 379: 359: 339: 314: 294: 266: 253: 240: 223: 213: 205: 177: 172: 137: 123: 93: 69: 61: 51: 46: 1264:"A critical review on Chagas disease chemotherapy" 1039: 1037: 1035: 703:. In Chagas disease it is a second-line option to 695:. For sleeping sickness it is used together with 1262:Rodriques Coura J, de Castro SL (January 2002). 824:and delayed hypersensitivity reaction involving 328: 928:. Mammalian cells are protected by presence of 303: 1567:. In Schaefer C, Peters PW, Miller RK (eds.). 2442:World Health Organization essential medicines 1902: 701:nifurtimox-eflornithine combination treatment 8: 1628: 1626: 1624: 1109: 1107: 1105: 112: 21: 1319:"Nifurtimox Drug Information, Professional" 1074: 1072: 1070: 1068: 1066: 198:In general: ℞ (Prescription only) 160: 2165: 1951: 1942: 1909: 1895: 1887: 1640:Centers for Disease Control and Prevention 1186: 1184: 1182: 1180: 1178: 1176: 1174: 1172: 509: 486: 368: 1799: 1747: 1694: 1531: 1485: 1444: 1367: 1279: 1208: 1160: 1143: 1141: 1139: 388: 1045:"Lampit- nifurtimox tablet, film coated" 2381: 1782:Sosa Estani S, Segura EL (1999-09-01). 1031: 779:Nifurtimox has also been used to treat 722:or in those with significant kidney or 644: 624: 611:180 to 182 °C (356 to 360 °F) 482: 348: 280: 500: 20: 1777: 1775: 1664: 1662: 1155:. Geneva: World Health Organization. 1090:from the original on 20 December 2016 455: 435: 85: 79: 7: 1882:. U.S. National Library of Medicine. 1600:"Nifurtimox use while Breastfeeding" 1345: 1343: 1313: 1311: 1309: 1307: 1305: 1303: 1301: 1299: 1243:from the original on 4 December 2016 150: 1720:Human & Experimental Toxicology 768:In the United States nifurtimox is 627:CC1CS(=O)(=O)CCN1N=CC2=CC=C(O2)(=O) 415: 408: 319: 1788:Memórias do Instituto Oswaldo Cruz 1474:The Journal of Infectious Diseases 1433:The Journal of Infectious Diseases 1268:Memórias do Instituto Oswaldo Cruz 749:Nifurtimox has been used to treat 14: 2384: 1585:from the original on 2017-09-08. 956: 687:, is a medication used to treat 540: 534: 38: 29: 1834:from the original on 2014-02-27 1801:10.1590/S0074-02761999000700070 1648:from the original on 2016-11-06 1610:from the original on 2016-11-08 1329:from the original on 2016-11-08 1281:10.1590/S0074-02762002000100001 652:Key:ARFHIAQFJWUCFH-UHFFFAOYSA-N 924:. These radicals are toxic to 552: 546: 528: 1: 1861:. Retrieved on July 10, 2009. 1524:10.1016/S0140-6736(09)61117-X 1675:Clinical Infectious Diseases 1406:10.1016/0035-9203(89)90270-8 1356:Clinical Infectious Diseases 1121:Food and Drug Administration 1115:"Lampit: FDA-Approved Drugs" 683:, sold under the brand name 807:Pregnancy and breastfeeding 16:Anti-parasitic medical drug 2463: 1740:10.1191/0960327106het653oa 518:Chemical and physical data 2335: 1828:World Health Organization 1468:Pepin J (February 2007). 1237:World Health Organization 1149:World Health Organization 965:This section needs to be 898:numbness of hands or feet 835:Most common side effects 798:Combination therapy with 739:World Health Organization 660: 635: 615: 271: 37: 28: 2417:Drugs developed by Bayer 1563:Padberg S (2014-09-17). 1210:10.1001/jama.298.18.2171 2084:Pentavalent antimonials 1956:African trypanosomiasis 1880:Drug Information Portal 1080:"Nifurtimox (Systemic)" 781:African trypanosomiasis 234:Cytochrome P450 oxidase 1851:Clinical trial number 993: 992:A bottle of nifurtimox 785:central nervous system 2092:Sodium stibogluconate 2088:Meglumine antimoniate 991: 2407:Antiprotozoal agents 2002:naphthalenesulfonate 1794:(Suppl 1): 363–365. 942:superoxide dismutase 861:Less common effects 1732:2006HETox..25..471C 948:Society and culture 911:Mechanism of action 25: 2362:Never to phase III 1859:ClinicalTrials.gov 1687:10.1093/cid/ciw477 1571:. Academic Press. 994: 726:. It is a type of 2372: 2371: 2331: 2330: 2155: 2154: 2109:phosphorylcholine 2059: 2058: 1239:. February 2016. 1203:(18): 2171–2181. 1051:. 27 January 2022 986: 985: 903:Contraindications 774:Trypanosoma cruzi 693:sleeping sickness 678: 677: 584:Interactive image 468:CompTox Dashboard 249:2.95 ± 1.19 hours 191: 106: 81:Drugs.com archive 2454: 2389: 2388: 2387: 2380: 2166: 1952: 1943: 1911: 1904: 1897: 1888: 1883: 1862: 1849: 1843: 1842: 1840: 1839: 1824:"Chagas disease" 1820: 1814: 1813: 1803: 1779: 1770: 1769: 1751: 1715: 1709: 1708: 1698: 1681:(8): 1056–1062. 1666: 1657: 1656: 1654: 1653: 1630: 1619: 1618: 1616: 1615: 1596: 1587: 1586: 1560: 1554: 1553: 1535: 1506: 1500: 1499: 1489: 1465: 1459: 1458: 1448: 1424: 1418: 1417: 1388: 1382: 1381: 1371: 1347: 1338: 1337: 1335: 1334: 1315: 1294: 1293: 1283: 1259: 1253: 1252: 1250: 1248: 1229: 1223: 1222: 1212: 1188: 1167: 1166: 1164: 1145: 1134: 1133: 1131: 1129: 1111: 1100: 1099: 1097: 1095: 1076: 1061: 1060: 1058: 1056: 1041: 981: 978: 972: 960: 959: 952: 755:gastrointestinal 674: 673: 666: 586: 566: 554: 548: 542: 536: 530: 513: 502: 491: 490: 476: 474: 459: 439: 419: 412: 392: 372: 352: 332: 322: 321: 307: 245: 189: 186: 164: 154: 116: 105: 102: 89: 83: 42: 33: 26: 24: 2462: 2461: 2457: 2456: 2455: 2453: 2452: 2451: 2437:Thiomorpholines 2397: 2396: 2395: 2385: 2383: 2375: 2373: 2368: 2367: 2352:Clinical trials 2327: 2292: 2272:Dientamoebiasis 2266: 2235: 2151: 2128: 2055: 2022: 2009: 1947:Trypanosomiasis 1932: 1915: 1874: 1871: 1866: 1865: 1850: 1846: 1837: 1835: 1822: 1821: 1817: 1781: 1780: 1773: 1717: 1716: 1712: 1668: 1667: 1660: 1651: 1649: 1632: 1631: 1622: 1613: 1611: 1598: 1597: 1590: 1579: 1562: 1561: 1557: 1518:(9683): 56–64. 1508: 1507: 1503: 1467: 1466: 1462: 1426: 1425: 1421: 1390: 1389: 1385: 1362:(10): e69–e75. 1349: 1348: 1341: 1332: 1330: 1317: 1316: 1297: 1261: 1260: 1256: 1246: 1244: 1231: 1230: 1226: 1190: 1189: 1170: 1147: 1146: 1137: 1127: 1125: 1113: 1112: 1103: 1093: 1091: 1078: 1077: 1064: 1054: 1052: 1043: 1042: 1033: 1028: 1020:medulloblastoma 1012: 1007: 999: 982: 976: 973: 970: 961: 957: 950: 913: 905: 895:muscle weakness 818: 809: 747: 669: 667: 664:(what is this?) 661: 656: 653: 648: 643: 642: 631: 628: 623: 622: 600:Racemic mixture 589: 564: 551: 545: 539: 533: 494: 470: 462: 442: 422: 395: 375: 355: 335: 318: 310: 290: 287: 279: 278: 243: 236:(CYP) involved) 215:Bioavailability 207:Pharmacokinetic 201: 168: 126: 119: 84: 17: 12: 11: 5: 2460: 2458: 2450: 2449: 2444: 2439: 2434: 2429: 2424: 2419: 2414: 2412:Chagas disease 2409: 2399: 2398: 2394: 2393: 2370: 2369: 2366: 2365: 2364: 2363: 2360: 2349: 2343: 2337: 2336: 2333: 2332: 2329: 2328: 2326: 2325: 2315: 2305: 2294: 2293: 2286: 2280:nitroimidazole 2276: 2274: 2268: 2267: 2265: 2264: 2249:nitroimidazole 2245: 2243: 2241:Trichomoniasis 2237: 2236: 2234: 2233: 2222: 2221: 2211: 2200: 2199: 2189: 2178:nitroimidazole 2174: 2172: 2163: 2157: 2156: 2153: 2152: 2150: 2149: 2146:Amphotericin B 2138: 2136: 2130: 2129: 2127: 2126: 2116: 2106: 2081: 2080: 2077:Amphotericin B 2069: 2067: 2061: 2060: 2057: 2056: 2054: 2053: 2043: 2036:nitroimidazole 2032: 2030: 2028:Chagas disease 2024: 2023: 2021: 2020: 2013:nitroimidazole 2010: 1999: 1989: 1971: 1960: 1958: 1949: 1940: 1934: 1933: 1918:Antiparasitics 1916: 1914: 1913: 1906: 1899: 1891: 1885: 1884: 1870: 1869:External links 1867: 1864: 1863: 1844: 1815: 1771: 1726:(8): 471–479. 1710: 1658: 1620: 1588: 1577: 1555: 1501: 1487:10.1086/510540 1480:(3): 311–313. 1460: 1446:10.1086/510534 1439:(3): 322–329. 1419: 1400:(4): 514–517. 1383: 1369:10.1086/656917 1339: 1295: 1254: 1224: 1168: 1135: 1101: 1062: 1030: 1029: 1027: 1024: 1011: 1008: 1006: 1003: 998: 995: 984: 983: 964: 962: 955: 949: 946: 912: 909: 904: 901: 900: 899: 896: 893: 890: 887: 884: 881: 878: 875: 872: 869: 866: 859: 858: 855: 852: 849: 846: 843: 840: 817: 814: 808: 805: 751:Chagas disease 746: 743: 724:liver problems 707:. It is given 689:Chagas disease 676: 675: 658: 657: 655: 654: 651: 649: 646: 638: 637: 636: 633: 632: 630: 629: 626: 618: 617: 616: 613: 612: 609: 603: 602: 597: 591: 590: 588: 587: 579: 577: 569: 568: 562: 556: 555: 549: 543: 537: 531: 526: 520: 519: 515: 514: 504: 496: 495: 493: 492: 479: 477: 464: 463: 461: 460: 452: 450: 444: 443: 441: 440: 432: 430: 424: 423: 421: 420: 413: 405: 403: 397: 396: 394: 393: 385: 383: 377: 376: 374: 373: 365: 363: 357: 356: 354: 353: 345: 343: 337: 336: 334: 333: 325: 323: 312: 311: 309: 308: 300: 298: 292: 291: 289: 288: 282: 274: 273: 272: 269: 268: 264: 263: 257: 251: 250: 247: 238: 237: 227: 221: 220: 217: 211: 210: 203: 202: 200: 199: 196: 183: 181: 175: 174: 170: 169: 167: 166: 143: 141: 135: 134: 129: 127:administration 121: 120: 118: 117: 99: 97: 91: 90: 77: 67: 66: 63: 59: 58: 55: 49: 48: 44: 43: 35: 34: 15: 13: 10: 9: 6: 4: 3: 2: 2459: 2448: 2445: 2443: 2440: 2438: 2435: 2433: 2430: 2428: 2425: 2423: 2420: 2418: 2415: 2413: 2410: 2408: 2405: 2404: 2402: 2392: 2382: 2378: 2361: 2359: 2356: 2355: 2353: 2350: 2347: 2344: 2342: 2339: 2338: 2334: 2323: 2319: 2316: 2313: 2309: 2306: 2303: 2299: 2296: 2295: 2290: 2287: 2285: 2284:Metronidazole 2281: 2278: 2277: 2275: 2273: 2269: 2262: 2258: 2257:Metronidazole 2254: 2250: 2247: 2246: 2244: 2242: 2238: 2231: 2227: 2226:aminoacridine 2224: 2223: 2219: 2215: 2212: 2209: 2205: 2202: 2201: 2197: 2193: 2192:benzimidazole 2190: 2187: 2183: 2182:Metronidazole 2179: 2176: 2175: 2173: 2171: 2167: 2164: 2162: 2158: 2147: 2143: 2140: 2139: 2137: 2135: 2131: 2124: 2120: 2117: 2114: 2110: 2107: 2104: 2100: 2097: 2096: 2095: 2093: 2089: 2085: 2078: 2074: 2071: 2070: 2068: 2066: 2065:Leishmaniasis 2062: 2051: 2047: 2044: 2041: 2037: 2034: 2033: 2031: 2029: 2025: 2018: 2014: 2011: 2007: 2003: 2000: 1997: 1993: 1990: 1987: 1983: 1979: 1975: 1972: 1969: 1965: 1962: 1961: 1959: 1957: 1953: 1950: 1948: 1944: 1941: 1939: 1938:Discicristata 1935: 1930: 1926: 1923: 1919: 1912: 1907: 1905: 1900: 1898: 1893: 1892: 1889: 1881: 1877: 1873: 1872: 1868: 1860: 1856: 1855: 1848: 1845: 1833: 1829: 1825: 1819: 1816: 1811: 1807: 1802: 1797: 1793: 1789: 1785: 1778: 1776: 1772: 1767: 1763: 1759: 1755: 1750: 1745: 1741: 1737: 1733: 1729: 1725: 1721: 1714: 1711: 1706: 1702: 1697: 1692: 1688: 1684: 1680: 1676: 1672: 1665: 1663: 1659: 1647: 1643: 1641: 1635: 1629: 1627: 1625: 1621: 1609: 1605: 1601: 1595: 1593: 1589: 1584: 1580: 1578:9780124079014 1574: 1570: 1566: 1559: 1556: 1551: 1547: 1543: 1539: 1534: 1529: 1525: 1521: 1517: 1513: 1505: 1502: 1497: 1493: 1488: 1483: 1479: 1475: 1471: 1464: 1461: 1456: 1452: 1447: 1442: 1438: 1434: 1430: 1423: 1420: 1415: 1411: 1407: 1403: 1399: 1395: 1387: 1384: 1379: 1375: 1370: 1365: 1361: 1357: 1353: 1346: 1344: 1340: 1328: 1324: 1323:www.drugs.com 1320: 1314: 1312: 1310: 1308: 1306: 1304: 1302: 1300: 1296: 1291: 1287: 1282: 1277: 1273: 1269: 1265: 1258: 1255: 1242: 1238: 1234: 1228: 1225: 1220: 1216: 1211: 1206: 1202: 1198: 1194: 1187: 1185: 1183: 1181: 1179: 1177: 1175: 1173: 1169: 1163: 1158: 1154: 1150: 1144: 1142: 1140: 1136: 1124: 1122: 1116: 1110: 1108: 1106: 1102: 1089: 1085: 1081: 1075: 1073: 1071: 1069: 1067: 1063: 1050: 1046: 1040: 1038: 1036: 1032: 1025: 1023: 1021: 1017: 1016:neuroblastoma 1009: 1004: 1002: 996: 990: 980: 968: 963: 954: 953: 947: 945: 943: 939: 935: 931: 927: 923: 919: 918:metronidazole 910: 908: 902: 897: 894: 891: 888: 885: 882: 879: 876: 873: 870: 867: 864: 863: 862: 856: 853: 850: 847: 844: 841: 838: 837: 836: 833: 831: 827: 823: 815: 813: 806: 804: 801: 796: 794: 790: 786: 782: 777: 775: 771: 766: 764: 760: 756: 752: 744: 742: 740: 736: 731: 729: 725: 721: 717: 712: 710: 706: 702: 698: 694: 690: 686: 682: 672: 665: 659: 650: 645: 641: 634: 625: 621: 614: 610: 608: 607:Melting point 604: 601: 598: 596: 592: 585: 581: 580: 578: 575: 570: 563: 561: 557: 527: 525: 521: 516: 512: 508: 505: 503: 501:ECHA InfoCard 497: 489: 485: 484:DTXSID3045439 481: 480: 478: 469: 465: 458: 454: 453: 451: 449: 445: 438: 434: 433: 431: 429: 425: 418: 414: 411: 407: 406: 404: 402: 398: 391: 387: 386: 384: 382: 378: 371: 367: 366: 364: 362: 358: 351: 347: 346: 344: 342: 338: 331: 327: 326: 324: 317: 313: 306: 302: 301: 299: 297: 293: 285: 281: 277: 270: 265: 261: 258: 256: 252: 248: 246: 239: 235: 231: 228: 226: 222: 218: 216: 212: 208: 204: 197: 195: 185: 184: 182: 180: 176: 171: 163: 158: 153: 148: 145: 144: 142: 140: 136: 133: 130: 128: 122: 115: 110: 101: 100: 98: 96: 92: 88: 82: 78: 76: 72: 68: 64: 60: 56: 54: 50: 47:Clinical data 45: 41: 36: 32: 27: 19: 2447:Orphan drugs 2308:tetracycline 2298:oxyquinoline 2218:Furazolidone 2208:Nitazoxanide 2082: 2049: 2040:Benznidazole 2017:Fexinidazole 1986:Tryparsamide 1968:Eflornithine 1920:directed at 1879: 1876:"Nifurtimox" 1852: 1847: 1836:. Retrieved 1827: 1818: 1791: 1787: 1723: 1719: 1713: 1678: 1674: 1650:. Retrieved 1637: 1612:. Retrieved 1603: 1568: 1558: 1515: 1511: 1504: 1477: 1473: 1463: 1436: 1432: 1422: 1397: 1393: 1386: 1359: 1355: 1331:. Retrieved 1322: 1271: 1267: 1257: 1245:. Retrieved 1236: 1227: 1200: 1196: 1162:10665/325771 1152: 1126:. Retrieved 1118: 1092:. Retrieved 1083: 1053:. Retrieved 1048: 1013: 1000: 997:Legal status 974: 966: 925: 914: 906: 860: 834: 819: 816:Side effects 810: 800:eflornithine 797: 778: 773: 767: 763:benznidazole 759:neurological 748: 745:Medical uses 732: 713: 705:benznidazole 697:eflornithine 684: 680: 679: 668:   662:   457:ChEMBL290960 283: 242:Elimination 179:Legal status 173:Legal status 95:License data 18: 2427:Nitrofurans 2348:from market 2322:Paromomycin 2312:Doxycycline 2289:Secnidazole 2253:Carnidazole 2196:Albendazole 2123:Paromomycin 2113:Miltefosine 2103:Pentamidine 2099:benzamidine 1996:Pentamidine 1992:benzamidine 1982:Melarsoprol 1854:NCT00601003 1749:11336/82805 1533:10144/72797 1274:(1): 3–24. 1055:23 February 977:August 2020 938:peroxidases 934:glutathione 880:sore throat 842:weight loss 822:anaphylaxis 793:melarsoprol 789:melarsoprol 567: g·mol 507:100.041.377 267:Identifiers 62:Other names 53:Trade names 2422:Hydrazones 2401:Categories 2302:Iodoquinol 2261:Tinidazole 2230:Quinacrine 2214:nitrofuran 2204:thiazolide 2186:Tinidazole 2170:Giardiasis 2050:Nifurtimox 2046:nitrofuran 1838:2016-11-08 1652:2016-11-09 1614:2016-11-07 1333:2016-11-09 1247:7 December 1094:3 December 1026:References 922:superoxide 868:depression 830:dermatitis 728:nitrofuran 681:Nifurtimox 572:3D model ( 560:Molar mass 437:CHEBI:7566 390:M84I3K7C2O 361:ChemSpider 305:23256-30-6 296:CAS Number 276:IUPAC name 262:, very low 225:Metabolism 114:Nifurtimox 65:Bayer 2502 23:Nifurtimox 2358:Phase III 2346:Withdrawn 2318:neomycin 2161:Trichozoa 1974:arsenical 1964:ornithine 1925:parasites 1604:Drugs.com 1084:Drugs.com 889:impotence 874:confusion 854:dizziness 770:indicated 720:pregnancy 595:Chirality 255:Excretion 244:half-life 125:Routes of 75:Drugs.com 2432:Sulfones 2391:Medicine 2119:neomycin 1922:excavata 1832:Archived 1810:10677756 1758:16937919 1705:27432838 1646:Archived 1608:Archived 1583:Archived 1550:32757305 1542:19559476 1496:17205466 1455:17205469 1378:20932171 1327:Archived 1290:11992141 1241:Archived 1219:18000201 1151:(2019). 1128:6 August 1088:Archived 1086:. 1995. 1049:DailyMed 1010:Research 930:catalase 926:T. cruzi 886:seizures 851:headache 848:vomiting 839:anorexia 709:by mouth 671:(verify) 341:DrugBank 157:QP51AC01 139:ATC code 132:By mouth 109:DailyMed 2142:polyene 2073:polyene 2006:Suramin 1766:8980212 1728:Bibcode 1696:5036918 1414:2694491 967:updated 892:tremors 871:anxiety 857:amnesia 826:icterus 741:(WHO). 524:Formula 350:DB11820 330:6842999 316:PubChem 159: ( 155:) 149: ( 147:P01CC01 111::  2377:Portal 2341:WHO-EM 1978:Atoxyl 1808:  1764:  1756:  1703:  1693:  1575:  1548:  1540:  1512:Lancet 1494:  1453:  1412:  1376:  1288:  1217:  940:, and 883:chills 845:nausea 716:cancer 685:Lampit 620:SMILES 565:287.29 448:ChEMBL 417:C08002 410:D00833 260:Kidney 194:℞-only 192: 107:  87:Lampit 57:Lampit 1762:S2CID 1642:(CDC) 1638:U.S. 1546:S2CID 1123:(FDA) 1119:U.S. 1005:Names 877:fever 640:InChI 574:JSmol 428:ChEBI 370:29464 230:Liver 1806:PMID 1754:PMID 1701:PMID 1573:ISBN 1538:PMID 1492:PMID 1451:PMID 1410:PMID 1374:PMID 1286:PMID 1249:2016 1215:PMID 1197:JAMA 1130:2020 1096:2016 1057:2023 1018:and 865:rash 828:and 757:and 691:and 401:KEGG 381:UNII 209:data 71:AHFS 2134:PAM 1929:P01 1796:doi 1744:hdl 1736:doi 1691:PMC 1683:doi 1528:hdl 1520:doi 1516:374 1482:doi 1478:195 1441:doi 1437:195 1402:doi 1364:doi 1276:doi 1205:doi 1201:298 1157:hdl 699:in 473:EPA 320:CID 219:Low 162:WHO 152:WHO 2403:: 2354:: 2259:, 2255:, 2184:, 2094:) 2090:, 1984:, 1980:, 1878:. 1830:. 1826:. 1804:. 1792:94 1790:. 1786:. 1774:^ 1760:. 1752:. 1742:. 1734:. 1724:25 1722:. 1699:. 1689:. 1679:63 1677:. 1673:. 1661:^ 1644:. 1636:. 1623:^ 1606:. 1602:. 1591:^ 1581:. 1544:. 1536:. 1526:. 1514:. 1490:. 1476:. 1472:. 1449:. 1435:. 1431:. 1408:. 1398:83 1396:. 1372:. 1360:51 1358:. 1354:. 1342:^ 1325:. 1321:. 1298:^ 1284:. 1272:97 1270:. 1266:. 1235:. 1213:. 1199:. 1195:. 1171:^ 1138:^ 1117:. 1104:^ 1082:. 1065:^ 1047:. 1034:^ 1022:. 936:, 932:, 776:. 730:. 711:. 538:13 532:10 188:US 104:US 2379:: 2324:) 2320:( 2314:) 2310:( 2304:) 2300:( 2291:) 2282:( 2263:) 2251:( 2232:) 2228:( 2220:) 2216:( 2210:) 2206:( 2198:) 2194:( 2188:) 2180:( 2148:) 2144:( 2125:) 2121:( 2115:) 2111:( 2105:) 2101:( 2086:( 2079:) 2075:( 2052:) 2048:( 2042:) 2038:( 2019:) 2015:( 2008:) 2004:( 1998:) 1994:( 1988:) 1976:( 1970:) 1966:( 1931:) 1927:( 1910:e 1903:t 1896:v 1841:. 1812:. 1798:: 1768:. 1746:: 1738:: 1730:: 1707:. 1685:: 1655:. 1617:. 1552:. 1530:: 1522:: 1498:. 1484:: 1457:. 1443:: 1416:. 1404:: 1380:. 1366:: 1336:. 1292:. 1278:: 1251:. 1221:. 1207:: 1159:: 1132:. 1098:. 1059:. 979:) 975:( 969:. 576:) 553:S 550:5 547:O 544:3 541:N 535:H 529:C 475:) 471:( 284:N 232:( 190:: 165:) 73:/

Index



Trade names
AHFS
Drugs.com
Drugs.com archive
Lampit
License data
DailyMed
Nifurtimox
Routes of
administration

By mouth
ATC code
P01CC01
WHO
QP51AC01
WHO
Legal status
℞-only
Pharmacokinetic
Bioavailability
Metabolism
Liver
Cytochrome P450 oxidase
Elimination half-life
Excretion
Kidney
IUPAC name
CAS Number
23256-30-6

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.